Open AccessMedicineBiology
L. Lue, Y. Kuo, A. Roher, L. Brachova, Yong Shen, L. Sue, T. Beach, J. Kurth, R. Rydel, J. Rogers
1999.9.1AMERICAN JOURNAL OF PATHOLOGY
tlooto Summary
Investigation revealed that Aβ40, whether in soluble or insoluble form, was a particularly useful measure for classifying ND, HPC, and AD patients compared with Aβ42, and it was found that concentrations of soluble Aβ clearly distinguished HPC from AD patients and were a strong inverse correlate of synapse loss.
Abstract
Abstract is not available.
Citation format
LUE, L., et al. Soluble amyloid β peptide concentration as a predictor of synaptic change in alzheimer’s disease. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155: 853–862.